Codice QR

Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Abstract Glioblastoma (GBM) is the most common primary brain cancer and is resistant to standard-of-care chemoradiation therapy (CRT). Magnetic hyperthermia therapy (MHT) exposes magnetic iron oxide nanoparticles (MIONPs) to an alternating magnetic field (AMF) to generate local hyperthermia. This st...

Descrizione completa

Salvato in:
Autori principali: Daniel Rivera, Alexandros Bouras, Milena Mattioli, Maria Anastasiadou, Anna Chiara Pacentra, Olivia Pelcher, Corrine Koziel, Alexander J. Schupper, Tori Chanenchuk, Hayden Carlton, Robert Ivkov, Constantinos G. Hadjipanayis
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Portfolio 2025-03-01
Serie:Scientific Reports
Soggetti:
Glioblastoma
Magnetic hyperthermia therapy
Magnetic iron-oxide nanoparticles
Radiation therapy
Temozolomide
Chemoradiation
Accesso online:https://doi.org/10.1038/s41598-025-95544-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi